A Powys man suffering from cancer has been told he will now receive a potentially life-enhancing drug after his local health board agreed to fund it.
Trevor Evans, of Rhayader, was told this week that he did not meet Powys Local Health Board criteria to receive the kidney cancer drug Nexavar, because he was not an “exceptional” case.
But his case was reviewed yesterday and he will now be provided with the drug for three months, before the situation is reviewed again.
The 57-year-old grandfather of seven was not receiving any treatment, despite the cancer spreading from his kidney to his bowel, lungs and liver.
But his daughter, Sarah Hope, today said she was delighted the LHB had changed the decision.
She said: “We only found out about it when I rang the LHB about something else, but we got some fantastic news. There is no cure for my father’s condition, but we want him to have extra time with his grandchildren and this drug would enable him to do this.”
Mr Evans was diagnosed with kidney cancer in November 2005 and had surgery in Hereford to remove his right kidney.
He was offered no after-treatment except regular scans, which were all-clear until June 2007, which showed tumours on his bowel, lung and liver.
He was initially prescribed Interferon – a drug that can help control or stabilise the cancer , but which had severe side-effects.
It was then suggested he applied for Nexavar, also known as Sorafenib.
A LHB spokeswoman said: “The chief executive can confirm that Mr Evans has been written to to confirm that he will be able to have the drug he requested for a three-month period before it is reviewed once more.”
See Also:
Share this article:
What are these?